Rare diseases
Investigational molecules
Locations
Study on DF1001, Nivolumab, and Paclitaxel for Patients with Advanced Solid Tumors
The NetherlandsStudy Comparing Weekly Low Dose Cisplatin to High Dose Every Three Weeks for Sarcopenic Patients with Head and Neck Cancer
The NetherlandsStudy of Ivosidenib or Enasidenib with Chemotherapy for Patients with Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome with IDH1 or IDH2 Mutation
The NetherlandsStudy on Adding Blinatumomab to Treatment for Adults with Precursor B-Acute Lymphoblastic Leukemia
The NetherlandsStudy Comparing Two Treatment Sequences of CDK4/6 Inhibitors (Abemaciclib, Palbociclib, or Ribociclib) in Hormone Receptor Positive Advanced Breast Cancer
The NetherlandsStudy of Trastuzumab, Pertuzumab, and Chemotherapy Combination with Response-Guided Treatment for Patients with HER2-Positive Breast Cancer
The NetherlandsStudy on Bevacizumab and Drug Combination for Patients with Resectable Colorectal Peritoneal Metastases
The NetherlandsStudy on Gemcitabine and Cisplatin for Patients After Surgery for Bile Duct or Gallbladder Cancer
The NetherlandsStudy of organ preservation using chemoradiotherapy and transanal surgery compared to standard surgery in patients with early rectal cancer (STAR-TREC trial)
The NetherlandsStudy of Brentuximab Vedotin Combined with R-DHAP Chemotherapy for Patients with Relapsed or Treatment-Resistant CD30-Positive Diffuse Large B-Cell Lymphoma Who Are Eligible for Stem Cell Transplant
The NetherlandsStudy on Bevacizumab with Temozolomide and Irinotecan for Children with Relapsed or Refractory Neuroblastoma
The NetherlandsStudy on Sentinel Lymph Node Mapping Using Gallium-68 Chloride and Tilmanocept in Patients with High-Risk Endometrial Cancer
The NetherlandsTell us about your condition – we search every trial in Europe and connect you with the right site.
